SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros (OMER) is trending intensely following the FDA approval of YARTEMLEA, its first and only therapy for transplant-associated thrombotic microangiopathy (TA-TMA), a critical condition with no prior approved treatments. The community is buzzing with speculation about the stock's significant undervaluation, potential for a short squeeze, and the possibility of a buyout from Novo Nordisk, building on their existing multi-billion dollar licensing deal.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Dynavax is trending sharply higher following the announcement of its acquisition by Sanofi, significantly boosting Sanofi's adult immunization portfolio with Heplisav-B and a promising shingles vaccine candidate. While many long-term investors express disappointment over the agreed price, viewing it as an undervaluation, others are relieved to see an exit after years of holding amid prior discussions about management's performance and shareholder value.

RAWW MILK COIN

RAWW MILK COIN is buzzing as its community highlights a year of sustained development and continuous content drops, from new webtoons and "Truth Series" videos to an album and game updates. The sentiment centers on RAWW building a unique "anti-degen" lifestyle and expanding into a full cultural universe, rather than just being a typical meme coin. This consistent delivery, even through market volatility, underscores its distinct philosophy and community-driven longevity.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display Technologies, Specialty Materials, Environmental Technologies, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computer, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Environmental Technologies segment focuses on manufacturing ceramic substrates and filter products for emissions control in mobile applications. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Corning is generating significant buzz following its strong financial performance and optimistic long-term growth projections, largely fueled by surging demand for its optical communications products critical for AI data centers. Community discussion highlights the company's essential role in AI infrastructure and the successful adoption of its Gorilla Glass innovations by major consumer electronics partners, leading many to anticipate further stock appreciation.

OpGen, Inc. is a precision medicine company, which engages in the power of molecular diagnostics and informatics to help combat infectious disease. It focuses on the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Clarksburg, MD.

Opgen Inc

Opgen (OPGN OTC) is trending due to its strategic pivot towards an AI-driven fintech platform, CapForce, which is generating significant community discussion around a potential Nasdaq relisting. Investors are closely watching recent SEC filings and the substantial insider ownership from AEI Capital, fueling speculation of a major valuation increase for this low-float stock focused on Asian digital investment banking.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biohaven is drawing significant attention after its depression drug failed a Phase 2 study and its SCA treatment received an FDA Complete Response Letter, leading to a company restructuring. Despite these setbacks, substantial insider buying and an intense community focus on highly anticipated data from its epilepsy, obesity, and oncology programs are driving conversations about potential future value. Investors are actively discussing whether the current valuation presents a strategic entry point for its diverse pipeline.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is gaining attention for its central role in Co-Packaged Optics (CPO) and Silicon Photonics, supplying crucial components for TSMC's COUPE platform, which is integral to advanced AI chips from major players like NVIDIA and AMD. The community is highly engaged, discussing the immense future revenue potential from this technology and emerging AR/AI applications, though some express impatience regarding the timeline for these innovations to significantly impact the company's financial results.

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Mimedx Group Inc

MiMedx Group is trending as recent CMS policy changes are poised to dramatically reshape the advanced wound care market by curbing fraud and prioritizing products with strong clinical evidence. The community is actively debating how these regulations will eliminate many higher-priced competitors, creating a significant market share opportunity for MDXG's proven offerings. Investors are keenly focused on how this shift towards evidence-based reimbursement could drive the company's long-term growth despite initial pricing adjustments.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos (ATOM) is trending as community discussions compare its interoperability vision and performance against emerging rivals like Keeta, which champions superior throughput and compliance-first architecture for institutional financial flows. Many investors express frustration over ATOM's prolonged price declines, which often overshadow its high staking rewards, amidst ongoing community efforts to redesign its tokenomics for long-term sustainability.

snowball is the first token in the world that uses the pumpfun creator fees to automatically marketmake itself aggressively.

snowball

SNOWBALL CRYPTO is trending due to community excitement surrounding its innovative script designed to combat "sneaky devs" and prevent "rug pulls," positioning it as a potential "game changer" for new launches on the Solana blockchain. Many users are optimistic about its early-stage potential to foster trust within the market, while some community members advise caution regarding potential pump and dump activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Art's-Way Manufacturing Co., Inc. engages in manufacturing and distributing farm equipment products. It also provides services relating to the design, manufacturing, delivery, installation and renting of the building units that it produces. It operates through the Agricultural Products and Modular Buildings segments. The Agricultural Products segment manufactures a variety of specialized farm machinery under its own label including portable and stationary animal feed processing equipment and related attachments used to mill and mix feed grains into custom animal feed rations, a line of forage equipment consisting of forage boxes, bale processors, running gear, and dump boxes, a line of manure spreaders, sugar beet harvesting equipment, and a line of dirt work equipment. The Modular Buildings segment produces and sells modular buildings, which are custom designed to meet the specific research needs of its customers. The company was founded by Arthur Luscombe in 1956 and is headquartered in Armstrong, IA.

ARTW
Art`s-way Manufacturing Co. Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest ARTW News

ARTWArt`s-way Manufacturing Co. Inc.